Growing community of inventors

Barcelona, Spain

Kim Pedersen

Average Co-Inventor Count = 5.46

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 10

Kim PedersenJosé Baselga Torres (4 patents)Kim PedersenJoaquin Arribas Lopez (2 patents)Kim PedersenPier-Davide Angellini (2 patents)Kim PedersenJosep Lluis Parra Palau (1 patent)Kim PedersenJosep Liuis Parra Palau (1 patent)Kim PedersenSirle Laos (1 patent)Kim PedersenJoaquín Arribas López (0 patent)Kim PedersenJosep Lluís Parra Palau (0 patent)Kim PedersenJoaquín Arribas López (0 patent)Kim PedersenJoaquín Arribas López (0 patent)Kim PedersenKim Pedersen (2 patents)José Baselga TorresJosé Baselga Torres (4 patents)Joaquin Arribas LopezJoaquin Arribas Lopez (2 patents)Pier-Davide AngelliniPier-Davide Angellini (2 patents)Josep Lluis Parra PalauJosep Lluis Parra Palau (1 patent)Josep Liuis Parra PalauJosep Liuis Parra Palau (1 patent)Sirle LaosSirle Laos (1 patent)Joaquín Arribas LópezJoaquín Arribas López (0 patent)Josep Lluís Parra PalauJosep Lluís Parra Palau (0 patent)Joaquín Arribas LópezJoaquín Arribas López (0 patent)Joaquín Arribas LópezJoaquín Arribas López (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Fundacio Privada Institut D'investigacio Oncologica De Vall Hebron (1 from 7 patents)

2. Fundacio Privada Institucio Catalana De Recerca I Estudis Avancats (1 from 2 patents)

3. Fundacio Privada Institut D'investigacio Oncologica De Vall D'hebron (1 from 2 patents)

4. Fundacio Privada Institucio Catalana De Recera I Estudis Avancats (1 from 1 patent)

5. Fundació Privada Institut De Recerca Hospital Universitari Vall Hebron (1 from 1 patent)

6. Fundació Privada Institució Catalana De Recerca I Estudis Avançants (0 patent)


2 patents:

1. 8741586 - Antibodies against HER2 truncated variant CTF-611

2. 8389227 - Method for diagnosing cancers expressing the HER2 receptor or its truncated variants

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/15/2025
Loading…